Haydarpasa Numune Training and Research Hospital; Medical Oncology

Istanbul 34668

0 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Ulcerative Colitis

Studies at this site

• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed